(Q46680012)

English

Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane

scientific article published in October 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16134178

Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16134178

0 references

1 reference

based on heuristic

inferred from title

breast carcinoma

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16134178

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16134178

Katherine S Panageas

3

object named as

Katherine S Panageas

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16134178

author name string

Monica N Fornier

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16134178

Clifford Hudis

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16134178

language of work or name

0 references

publication date

1 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16134178

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16134178

104

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16134178

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16134178

1575-1579

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16134178

Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21385

21 January 2018

Scheduling of fluorouracil: a forget-me-not in the jungle of doublets

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21385

21 January 2018

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21385

7 January 2021

based on heuristic

inferred from DOI database lookup

Web-based survey of fertility issues in young women with breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21385

7 January 2021

based on heuristic

inferred from DOI database lookup

Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21385

7 January 2021

based on heuristic

inferred from DOI database lookup

Side effects of adjuvant treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21385

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of chemotherapy-induced amenorrhea depending on the timing of treatment by menstrual cycle phase in women with early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21385

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21385

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21385

7 January 2021

based on heuristic

inferred from DOI database lookup

Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21385

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of menopause during the first year after breast cancer diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21385

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of action of adjuvant chemotherapy in early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21385

7 January 2021

based on heuristic

inferred from DOI database lookup

Fertility and the impact of systemic therapy on hormonal status following treatment for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21385

7 January 2021

based on heuristic

inferred from DOI database lookup

The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. The International Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21385

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Cli

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21385

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.21385

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16134178

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16134178

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46680012&oldid=2125920831"